瘤生物学:利用微生物组转化研究在免疫瘤学,临床实践的变化
Carolina Alves Costa Silva1,2, Andrew A Almonte1,2, Laurence Zitvogel1,2,3,4
1Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94805 Villejuif, France.
Biomolecules
|April 30, 2025
概括
癌症不仅涉及遗传学;肠道微生物群 (微生物群) 的干扰会影响免疫力和新陈代谢. 基于微生物群的策略显示出癌症预防和治疗的前景.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 代谢过程中的代谢.
背景情况:
- 癌症越来越多地被认为与宿主元生物的功能缺陷有关,包括肠道失调.
- 人类微生物群极大地影响肠道屏障功能,宿主新陈代谢和抗癌免疫反应.
- 像ONCOBIOME这样的国际合作对于推动微生物组研究和生物标志物发现至关重要.
研究的目的:
- 探索微生物组,宿主新陈代谢和癌症免疫之间的复杂相互作用.
- 为癌症预防和治疗提出基于微生物群的新策略.
主要方法:
- 关于微生物组,新陈代谢和癌症的当前科学文献的综述.
- 分析肠道失生症在癌症发展和进展中的作用.
- 讨论国际研究网络的贡献.
主要成果:
- 肠道微生物组显著影响上皮质屏障完整性,新陈代谢和全身免疫力.
- 微生物群失生症是癌症发病的一个关键因素.
- 来自微生物群的生物标志物和疗法有可能改善癌症的结果.
结论:
- 看癌症超越遗传学,结合基于微生物组的方法,至关重要.
- 准微生物组为增强癌症预防和治疗策略提供了一个有希望的途径.
- 需要进一步的研究和协作努力,才能充分利用微生物组在瘤学中的潜力.
相关概念视频
01:27Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K